Se and Temaz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Se (selenium) and Temaz (temazepam). Common drug interactions include tongue discolouration among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Se and Temaz. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Se?

Se has active ingredients of selenium. eHealthMe is studying from 5,604 Se users. Check the latest studies of Se.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.



On Aug, 01, 2026

70 people who take Se and Temaz together, and have interactions are studied.

Se and Temaz drug interactions.

What are the common drug interactions of Se and Temaz, by gender? *:

female:

  1. Tongue discolouration (colour change of tongue)
  2. Depression
  3. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  4. Acne (skin problems that cause pimples)
  5. Impetigo (contagious skin infection)
  6. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  7. Peripheral coldness
  8. Stomatitis (inflammation of mucous membrane of mouth)
  9. Tongue geographic (irregular patches on the surface of the tongue)
  10. Balance disorder

male:

  1. Drug ineffective
  2. Wheezing (a high-pitched whistling sound made while you breath)
  3. Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries))
  4. Memory impairment
  5. Pain
  6. Pyrexia (fever)
  7. Rib fracture
  8. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  9. Sleep disorder
  10. Weight decreased

What are the common drug interactions of Se and Temaz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Back pain
  2. Chest pain

40-49:

  1. Alopecia (absence of hair from areas of the body)
  2. Anger
  3. Back pain
  4. Decreased interest
  5. Depression
  6. Hypotension (abnormally low blood pressure)
  7. Neuropathy peripheral (surface nerve damage)
  8. Oral mucosal blistering (mouth ulcer)
  9. Pruritus (severe itching of the skin)

50-59:

  1. Hostility
  2. Hyperhidrosis (abnormally increased sweating)
  3. Hypoacusis (loss of hearing)
  4. Irritability
  5. Lethargy (tiredness)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Mania (a state of abnormally elevated or irritable mood)
  8. Oral pain
  9. Osteomyelitis (infection of bone)
  10. Rhinorrhoea (watery mucus discharge from the nose)

60+:

  1. Fall
  2. Memory impairment
  3. Anxiety
  4. Arthralgia (joint pain)
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Chronic kidney disease
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Diarrhoea
  9. Drug ineffective
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Sleep Disorder: 18 people, 25.71%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 18 people, 25.71%
  3. Constipation: 16 people, 22.86%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 16 people, 22.86%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 16 people, 22.86%
  6. Hair Loss: 15 people, 21.43%
  7. Stress And Anxiety: 8 people, 11.43%
  8. Multiple Myeloma (cancer of the plasma cells): 6 people, 8.57%
  9. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 7.14%
  10. Asthma: 5 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Se and Temaz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Se and Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Se:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Se and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on selenium and temazepam (the active ingredients of Se and Temaz, respectively), and Se and Temaz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: